ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma MK Andersson, G Mangiapane, PT Nevado, A Tsakaneli, T Carlsson, ... Oncogenesis 9 (1), 5, 2020 | 49 | 2020 |
Identification of a c-MYB-directed therapeutic for acute myeloid leukemia K Clesham, V Walf-Vorderwülbecke, L Gasparoli, C Virely, S Cantilena, ... Leukemia 36 (6), 1541-1549, 2022 | 16 | 2022 |
Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements A Tsakaneli, O Williams Frontiers in Pharmacology 12, 741413, 2021 | 12 | 2021 |
Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac S Bibbo’, A Lamolinara, E Capone, S Purgato, A Tsakaneli, V Panella, ... Oncogenesis 9 (1), 3, 2020 | 8 | 2020 |
MYC regulates metabolism through vesicular transfer of glycolytic kinases A Tsakaneli, VC Carregari, M Morini, A Eva, G Cangemi, O Chayka, ... Open biology 11 (12), 210276, 2021 | 7 | 2021 |
Susceptibility of pediatric acute lymphoblastic leukemia to STAT3 inhibition depends on p53 induction L Gasparoli, C Virely, A Tsakaneli, N Che, D Edwards, J Bartram, ... Haematologica 109 (4), 1069, 2024 | | 2024 |
MYCN Regulates the Oncogenic Activity of Exosomes in Neuroblastoma: Potential Role of PKM2 A Tsakaneli, G Palmisano, A Sala | | |